MLND
Millendo Therapeutics Inc
Halal Rating :
Last Price
$0.93
Last updated:
Market Cap
-
7D Change
0.87%
1 Year Change
-76.97%
Company Overview
Exchange
Next Earnings Date
Note: Millendo Therapeutics Inc. merged with Tempest Therapeutics in June 2021. The combined company now operates as Tempest Therapeutics (NASDAQ: TPST).
Millendo Therapeutics was a clinical-stage biopharmaceutical company focused on developing novel treatments for endocrine diseases. The company's main focus was on developing treatments for rare endocrine diseases including Prader-Willi syndrome and congenital adrenal hyperplasia.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Millendo Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.